Thus, the tumor immune evasion mechanism that up-regulation of CEACAM1 or CEACAM5 activates inhibitory CEACAM1 signaling in NK cells and then circumvents NK cytotoxicity also exists in colorectal cancer cells. This evidence concerns the gene CEACAM5 and neoplasm.